Seagen to Present at the J.P. Morgan Healthcare Conference

BOTHELL, Wash.--(BUSINESS WIRE)-- Seagen Inc. (Nasdaq: SGEN) today announced that management will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 3:00 p.m. Eastern Time. The presentation will be webcast live and available for replay from the investor section of Seagen’s website at investor.seagen.com.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211220005153/en/

For Investors
Peggy Pinkston
Senior Vice President, Investor Relations
(425) 527-4160
[email protected]

For Media
David Caouette
Vice President, Corporate Communications
(310) 430-3476
[email protected]

Source: Seagen Inc.

You May Also Be Interested In

• Avnet Increases Quarterly Dividend by 5.7%
• K-EnterTech Shines on the Global Stage! BIGC Wins Four Awards, Including the Stevie Awards and Good Design Awards
• FSH Technologies Raises $25 Million to Take On The Consulting Firms Running Up The Bill on American Taxpayers